At a glance
ClinicalIndex Comparison RecordN/ACompleted· 127 enrolled
Drug / intervention
Enbreldrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Correlation of Anti-CCP With Disease Activity and Its Impact on Biological Response in PsA in Iraqi Patients
In Brief
An observational study evaluating Enbrel for Psoriatic Arthritis. Completed, enrolled 127 participants across 1 site.
Detailed Summary
This study is to evaluate the local data in Iraqi patients with psoriatic arthritis on Enbrel treatment with positive Anti-Cyclic Citrullinated Peptide using data from the Rheumatologist in Baghdad Teaching Hospital registry.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPsoriatic Arthritis
CountriesIraq
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedJun 2020
Enrollment StartJul 2020
Primary CompletionAug 2020
TodayJul 2026
First PostedJun 11, 2020
Enrollment StartJul 5, 2020
Primary CompletionAug 30, 2020
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 6.1 years ago
Interventions
Enbreldrug
As provided in real world practice